Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:00 UTC |
---|
HMDB ID | HMDB0000269 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Sphinganine |
---|
Description | Sphinganine belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, sphinganine is considered to be a sphingoid base lipid molecule. Sphinganine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Sphinganine exists in all living species, ranging from bacteria to humans. Within humans, sphinganine participates in a number of enzymatic reactions. In particular, sphinganine can be converted into 3-dehydrosphinganine through its interaction with the enzyme 3-ketodihydrosphingosine reductase. In addition, sphinganine can be converted into sphinganine 1-phosphate; which is catalyzed by the enzyme sphingosine kinase 2. Outside of the human body, sphinganine has been detected, but not quantified in, several different foods, such as Mexican oregano, jostaberries, winter squash, angelica, and epazotes. This could make sphinganine a potential biomarker for the consumption of these foods. Sphinganine blocks postlysosomal cholesterol transport by inhibiting low-density lipoprotein-induced esterification of cholesterol and causing unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested that endogenous sphinganine may inhibit cholesterol transport in Niemann-Pick Type C (NPC) disease (PMID: 1817037 ). |
---|
Structure | CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/t17-,18+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(2S,3R)-2-Amino-1,3-octadecanediol | ChEBI | (2S,3R)-2-Aminooctadecane-1,3-diol | ChEBI | (R-(R*,s*))-2-aminooctadecane-1,3-diol | ChEBI | 2-Amino-1,3-dihydroxyoctadecane | ChEBI | C18-Dihydrosphingosine | ChEBI | C18-Sphinganine | ChEBI | D-Erythro-1,3-dihydroxy-2-aminooctadecane | ChEBI | D-Erythro-2-amino-1,3-octadecanediol | ChEBI | D-Erythro-C18-dihydrosphingosine | ChEBI | D18:0 | ChEBI | Dihydrosphingosine | ChEBI | Octadecasphinganine | ChEBI | Safingol | ChEBI | Erythro-D-sphinganine | HMDB | 2-Aminooctadecane-1,3-diol | HMDB | Threo-dihydrosphingosine | HMDB | 2-Amino-D-erythro-1,3-octadecanediol | HMDB | C18-Dihydro-sphingosine | HMDB | D-Erythro-sphinganine | HMDB | Dihydro-C18-sphingosine | HMDB | Erythro-sphinganine | HMDB | [R-(R*,s*)]-2-amino-1,3-octadecanediol | HMDB | (2S,3R)-Sphinganine | HMDB | D-Erythro-dihydrosphingosine | HMDB | SP(D18:0) | HMDB | Sphinganine | HMDB |
|
---|
Chemical Formula | C18H39NO2 |
---|
Average Molecular Weight | 301.5078 |
---|
Monoisotopic Molecular Weight | 301.298079497 |
---|
IUPAC Name | (2S,3R)-2-aminooctadecane-1,3-diol |
---|
Traditional Name | sphinganine |
---|
CAS Registry Number | 764-22-7 |
---|
SMILES | CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO |
---|
InChI Identifier | InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/t17-,18+/m0/s1 |
---|
InChI Key | OTKJDMGTUTTYMP-ZWKOTPCHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | 1,2-aminoalcohols |
---|
Alternative Parents | |
---|
Substituents | - Secondary alcohol
- 1,2-aminoalcohol
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Primary alcohol
- Organooxygen compound
- Primary aliphatic amine
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Sphinganine,1TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@@H](N)CO | 2451.1 | Semi standard non polar | 33892256 | Sphinganine,1TMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO[Si](C)(C)C | 2450.2 | Semi standard non polar | 33892256 | Sphinganine,1TMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)N[Si](C)(C)C | 2521.2 | Semi standard non polar | 33892256 | Sphinganine,2TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@@H](N)CO[Si](C)(C)C | 2505.8 | Semi standard non polar | 33892256 | Sphinganine,2TMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO)N[Si](C)(C)C | 2548.6 | Semi standard non polar | 33892256 | Sphinganine,2TMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C)N[Si](C)(C)C | 2538.8 | Semi standard non polar | 33892256 | Sphinganine,2TMS,isomer #4 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)N([Si](C)(C)C)[Si](C)(C)C | 2669.9 | Semi standard non polar | 33892256 | Sphinganine,3TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N[Si](C)(C)C | 2568.5 | Semi standard non polar | 33892256 | Sphinganine,3TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N[Si](C)(C)C | 2647.3 | Standard non polar | 33892256 | Sphinganine,3TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N[Si](C)(C)C | 2524.8 | Standard polar | 33892256 | Sphinganine,3TMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO)N([Si](C)(C)C)[Si](C)(C)C | 2769.6 | Semi standard non polar | 33892256 | Sphinganine,3TMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO)N([Si](C)(C)C)[Si](C)(C)C | 2680.2 | Standard non polar | 33892256 | Sphinganine,3TMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO)N([Si](C)(C)C)[Si](C)(C)C | 2625.0 | Standard polar | 33892256 | Sphinganine,3TMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2755.7 | Semi standard non polar | 33892256 | Sphinganine,3TMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2717.1 | Standard non polar | 33892256 | Sphinganine,3TMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2713.9 | Standard polar | 33892256 | Sphinganine,4TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2825.5 | Semi standard non polar | 33892256 | Sphinganine,4TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2735.7 | Standard non polar | 33892256 | Sphinganine,4TMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2471.7 | Standard polar | 33892256 | Sphinganine,1TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](N)CO | 2685.6 | Semi standard non polar | 33892256 | Sphinganine,1TBDMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO[Si](C)(C)C(C)(C)C | 2688.5 | Semi standard non polar | 33892256 | Sphinganine,1TBDMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)N[Si](C)(C)C(C)(C)C | 2763.6 | Semi standard non polar | 33892256 | Sphinganine,2TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](N)CO[Si](C)(C)C(C)(C)C | 2956.5 | Semi standard non polar | 33892256 | Sphinganine,2TBDMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO)N[Si](C)(C)C(C)(C)C | 3015.0 | Semi standard non polar | 33892256 | Sphinganine,2TBDMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2983.5 | Semi standard non polar | 33892256 | Sphinganine,2TBDMS,isomer #4 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3111.9 | Semi standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 3244.7 | Semi standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 3156.5 | Standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2889.1 | Standard polar | 33892256 | Sphinganine,3TBDMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3404.5 | Semi standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3180.3 | Standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #2 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2909.7 | Standard polar | 33892256 | Sphinganine,3TBDMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3392.1 | Semi standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3200.2 | Standard non polar | 33892256 | Sphinganine,3TBDMS,isomer #3 | CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2983.4 | Standard polar | 33892256 | Sphinganine,4TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3656.7 | Semi standard non polar | 33892256 | Sphinganine,4TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3346.7 | Standard non polar | 33892256 | Sphinganine,4TBDMS,isomer #1 | CCCCCCCCCCCCCCC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2886.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Sphinganine GC-MS (3 TMS) | splash10-0udi-3980100000-87c0074f611dec416856 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Sphinganine GC-MS (3 TMS) | splash10-0udi-1690000000-8fed2f980c631302b97b | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Sphinganine GC-MS (Non-derivatized) | splash10-0udi-3980100000-87c0074f611dec416856 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Sphinganine GC-MS (Non-derivatized) | splash10-0udi-1690000000-8fed2f980c631302b97b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-9120000000-0cfd71520376dffc3c78 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (2 TMS) - 70eV, Positive | splash10-0uk9-4490200000-f4c4281643554b83dd43 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sphinganine GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-ITFT , negative-QTOF | splash10-0159-0092000000-6e15bf1516b938239cb5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 25V, Negative-QTOF | splash10-0159-0092000000-9c001535e8080ffe05e2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0iml-3791000000-013fe5eb404ccb287385 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-03di-9000000000-04469479cb6d83603093 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0bt9-9000000000-4f682b26d6efc1673141 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0udi-0009000000-4d5daf40edf51d7c5ce4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0f89-2196000000-86bd4d9593c5a53dfc94 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-01qa-9130000000-819bc3df8d7408799b9f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-03xr-9000000000-0b47410c79f07946095a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-03xr-9000000000-6dd6eb4c242974e7f7cc | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-qTof , Positive-QTOF | splash10-0ab9-3892000000-6d8fa67090a1cebaa6f3 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ , positive-QTOF | splash10-0udi-0009000000-4d5daf40edf51d7c5ce4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ , positive-QTOF | splash10-0f89-2196000000-86bd4d9593c5a53dfc94 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ , positive-QTOF | splash10-01qa-9130000000-819bc3df8d7408799b9f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ , positive-QTOF | splash10-03xr-9000000000-3157cbca45e3dce158e4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine LC-ESI-QQ , positive-QTOF | splash10-03xr-9000000000-6dd6eb4c242974e7f7cc | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine , positive-QTOF | splash10-0udi-2390000000-a002411e49400899cf3c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 10V, Positive-QTOF | splash10-0gx0-5096000000-ad6ab79ab16fab02d693 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 40V, Positive-QTOF | splash10-08fr-9000000000-5afe9071156e7abc48f2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 20V, Positive-QTOF | splash10-03e9-9040000000-8a6a0ab6b7747fee43d6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 40V, Positive-QTOF | splash10-08fr-9000000000-666ced30bce6b3bc1819 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 20V, Positive-QTOF | splash10-03e9-9030000000-2256d1f455c1953799fb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 20V, Positive-QTOF | splash10-0f89-4095000000-742eb2c9ed03a93559fd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 35V, Positive-QTOF | splash10-08gi-4590000000-6dc187f1b434d586c78f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sphinganine 20V, Positive-QTOF | splash10-0f89-4096000000-3411dcd7c276cabc4ff9 | 2021-09-20 | HMDB team, MONA | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Disease References | Colorectal cancer |
---|
- Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14. [PubMed:25105552 ]
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Pregnancy |
---|
- Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70. [PubMed:12698507 ]
|
|
---|
General References | - Ribar S, Mesaric M, Bauman M: High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in Croatia. J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):511-9. [PubMed:11339295 ]
- van der Westhuizen L, Shephard GS, van Schalkwyk DJ: The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys. Toxicon. 2001 Jul;39(7):969-72. [PubMed:11223085 ]
- van der Westhuizen L, Brown NL, Marasas WF, Swanevelder S, Shephard GS: Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. Food Chem Toxicol. 1999 Dec;37(12):1153-8. [PubMed:10654591 ]
- Deguchi H, Yegneswaran S, Griffin JH: Sphingolipids as bioactive regulators of thrombin generation. J Biol Chem. 2004 Mar 26;279(13):12036-42. Epub 2004 Jan 13. [PubMed:14722105 ]
- Flamand N, Justine P, Bernaud F, Rougier A, Gaetani Q: In vivo distribution of free long-chain sphingoid bases in the human stratum corneum by high-performance liquid chromatographic analysis of strippings. J Chromatogr B Biomed Appl. 1994 Jun 3;656(1):65-71. [PubMed:7952048 ]
- Martinez G, Jimenez-Sanchez G, Divry P, Vianey-Saban C, Riudor E, Rodes M, Briones P, Ribes A: Plasma free fatty acids in mitochondrial fatty acid oxidation defects. Clin Chim Acta. 1997 Nov 28;267(2):143-54. [PubMed:9469249 ]
- Berg C, Trofast C, Bengtsson T: Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts. Eur J Cell Biol. 2003 Nov;82(11):565-71. [PubMed:14703013 ]
- Voss KA, Plattner RD, Riley RT, Meredith FI, Norred WP: In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia. 1998;141(1):45-58. [PubMed:9725030 ]
- Bouchon B, Portoukalian J, Orgiazzi J, Bornet H: Selective enrichment of phytosphingosine in glycosphingolipids of isolated human thyrocytes as compared to the whole thyroid. Biochem Biophys Res Commun. 1987 Mar 30;143(3):827-31. [PubMed:3566758 ]
- Dragusin M, Gurgui C, Schwarzmann G, Hoernschemeyer J, van Echten-Deckert G: Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells. J Lipid Res. 2003 Sep;44(9):1772-9. Epub 2003 Jun 1. [PubMed:12777464 ]
- Sharma N, He Q, Sharma RP: Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells. Chem Biol Interact. 2004 Dec 30;151(1):33-42. [PubMed:15607760 ]
- Bibel DJ, Aly R, Shinefield HR: Topical sphingolipids in antisepsis and antifungal therapy. Clin Exp Dermatol. 1995 Sep;20(5):395-400. [PubMed:8593716 ]
- Dyatlovitskaya EV, Kandyba AG, Kozlov AM, Somova OG: Sphinganine in sphingomyelins of tumors and mouse regenerating liver. Biochemistry (Mosc). 2001 May;66(5):502-4. [PubMed:11405884 ]
- Zimber A, Chedeville A, Gespach C, Abita JP: Inhibition of proliferation and induction of monocytic differentiation on HL60 human promyelocytic leukemia cells treated with bile acids in vitro. Int J Cancer. 1994 Oct 1;59(1):71-7. [PubMed:7927907 ]
- Rodriguez-Lafrasse C, Rousson R, Pentchev PG, Louisot P, Vanier MT: Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders. Biochim Biophys Acta. 1994 May 25;1226(2):138-44. [PubMed:8204660 ]
- Roff CF, Goldin E, Comly ME, Cooney A, Brown A, Vanier MT, Miller SP, Brady RO, Pentchev PG: Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev Neurosci. 1991;13(4-5):315-9. [PubMed:1817037 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|